• Specialties
  • Topics
  • Journal
  • Conference
  • Institutional
    • Allergy
    • Anesthesiology
    • Cardiology
    • Cosmetic Surgery
    • Critical Care
    • Dermatology
    • Diabetes & Endocrinology
    • Emergency Medicine
    • Family Practice
    • Gastroenterology
    • Geriatrics
    • Hematology & Oncology
    • HIV & AIDS
    • Infectious Disease
    • Internal Medicine
    • Nephrology
    • Neurology
    • Nursing
    • OBGYN &Women’s Health
    • Ophthalmology
    • Orthopedics
    • Otolaryngology
    • Pain Management
    • Pathology
    • Pediatrics
    • Pharmacy
    • Psychiatry
    • Pulmonology
    • Radiology
    • Rheumatology
    • Surgery
    • Urology

  • What's Popular

    • Prescription Drugs
    • Heart / Stroke-Related
    • Surgery: Misc.
    • Kids
    • Doctors
    • Infections
    • Diabetes: Misc.
    • Diabetes: Type II
    • Pregnancy
    • Cancer: Misc.
    • All Topics

  • What's Popular

    • Category 1

  • What's Popular

    • Category 1
  • Medical News
  • >
  • Prescription Drugs

Latest Prescription Drugs news

Uptake Low for Monoclonal Antibodies for COVID-19

posted September 22nd
by modernClinician Editorial Team

Oxcarbazepine Tied to Nontrauma Fracture in Children Aged 4 to 13 With Epilepsy

posted September 22nd
by modernClinician Editorial Team

Adding Pembrolizumab to Chemo Ups Survival in Cervical Cancer

posted September 21st
by modernClinician Editorial Team

Americans Struggling With High Cost of Prescription Drugs

posted September 20th
by modernClinician Editorial Team

Editor's Recommendations

Families of Children With Special Needs Lose Average $18,000 Income Annually

Pfizer Recalls All Lots of Chantix Due to Potential Carcinogen

Hospitalizing the Unvaccinated Has Cost U.S. Nearly $6 Billion

Most With AD, MCI Would Have Been Excluded From Aducanumab Clinical Trials

Related Articles

Government Buys More Monoclonal Antibody Treatments to Ward Off Shortage

Isotretinoin Does Not Up Suicide Risk in Acne Patients

Some Cancer Drugs Without Proven Benefit Still Recommended

Baricitinib Does Not Cut COVID-19 Progression in Hospitalized Adults

Monthly Specialist Briefings

  • September 2020 Briefing - Surgery
  • September 2020 Briefing - Diabetes & Endocrinology
  • September 2020 Briefing - Urology
  • September 2020 Briefing - Family Practice
  • September 2020 Briefing - Internal Medicine
  • September 2020 Briefing - Gastroenterology
  • September 2020 Briefing - Critical Care
  • September 2020 Briefing - HIV & AIDS
  • September 2020 Briefing - Emergency Medicine
  • September 2020 Briefing - Infectious Disease
  • September 2020 Briefing - Otolaryngology
  • September 2020 Briefing - Neurology
  • September 2020 Briefing - Nephrology
  • September 2020 Briefing - Nursing
  • September 2020 Briefing - Pathology
  • September 2020 Briefing - OBGYN & Women's Health
  • September 2020 Briefing - Radiology
  • September 2020 Briefing - Hematology & Oncology
  • September 2020 Briefing - Anesthesiology
  • September 2020 Briefing - Ophthalmology
  • September 2020 Briefing - Cosmetic Surgery
  • September 2020 Briefing - Orthopedics
  • September 2020 Briefing - Geriatrics
  • September 2020 Briefing - Pediatrics
  • September 2020 Briefing - Pain Management
  • September 2020 Briefing - Psychiatry
  • September 2020 Briefing - Pharmacy
  • September 2020 Briefing - Pulmonology
  • September 2020 Briefing - Rheumatology

Stay Connected

About
  • About Us
  • Privacy Policy
  • Terms of Use
  • Advertising
Connect - test
  • Facebook
  • Twitter